Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
JUBLPHARMA
₹972
₹964.10
₹988.40
₹786.05
₹1248.00
Markets Today
Historical Performance
As of 09-07-2026 17:16, Jubilant Pharmova Ltd. share price today is ₹0, with a change of ₹-970.75 (-100.00%) from the previous close of ₹970.75. The stock opened at ₹978 and traded between ₹964.1 and ₹988.4, with a total traded volume of 102229 shares. The company has a market capitalization of ₹15590.4 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1248 and ₹786.05, respectively.
Jubilant Pharmova Ltd. valuation metrics include a P/E ratio of 39.1, EPS of ₹25.15, and book value of ₹2.20. Profitability indicators show ROE of 5.61% along with a dividend yield of 0.5%. Jubilant Pharmova Ltd. has reported revenue of ₹8279.6 Cr and net profit of ₹398.5 Cr.
Jubilant Pharmova Ltd. technical indicators include Day RSI at 52.6, Day MFI at 56.24, Day ADX at 15.15. Additional indicators include Commodity Channel Index (CCI) at 83.8 and Williams %R at -40.56. Momentum indicators show Day MACD at 0.8, Day MACD Signal Line at 0.22, DayATR at 26. Rate of Change indicators for Jubilant Pharmova Ltd. include ROC125 at -8.8 and ROC21 at 0.53.
Exponential moving averages include EMA5 at ₹975.6, EMA10 at ₹973.5, EMA12 at ₹973.3, EMA20 at ₹973.2, EMA26 at ₹972.5, EMA50 at ₹964.9, EMA100 at ₹962.8, EMA200 at ₹980.2. Simple moving averages include SMA5 at ₹975.8, SMA10 at ₹971.4, SMA20 at ₹971.7, SMA30 at ₹975.2, SMA50 at ₹976, SMA100 at ₹924.6, SMA150 at ₹963.4, SMA200 at ₹999.7.
Support levels for Jubilant Pharmova are placed at First Support ₹969.53, Second Support ₹960.27, Third Support ₹947.33. Resistance levels are seen at First Resistance ₹991.73, Second Resistance ₹1004.67, Third Resistance ₹1013.93. Jubilant Pharmova Ltd. shareholding pattern shows promoter holding at 47.68%, FII holding at 15.9%, DII holding at 0%, public holding at 24.25%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 70.30 | 67.30 | 66.40 | 59.50 | 217.30 |
| Operating Expense | 55.80 | 55.10 | 54.60 | 49.20 | 191.30 |
| Operating Profit | 14.50 | 12.20 | 11.80 | 10.30 | 26 |
| Depreciation | 1.30 | 1.60 | 1.60 | 1.50 | 13.40 |
| Interest | 0.90 | 0.90 | 2.50 | 3 | 7 |
| Tax | -53.10 | 3.50 | 56.50 | 2.40 | 9.90 |
| Net Profit | 57.20 | 6.60 | -6.40 | 5.80 | 13.60 |
₹972.00
↗ Bullish Moving Average
14
↘ Bearish Moving Average
2
| Held By |
|---|
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 59.34 K | 1.13 L | 52.35% |
| Week | 48.7 K | 91.42 K | 53.27% |
| 1 Month | 47.32 K | 98.57 K | 48.01% |
| 6 Month | 73.81 K | 1.5 L | 49.34% |
Benjamin Graham Value Screen
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 24 Jul, 2026 | 5 | FINAL | 24 Jul, 2026 | Equity Share |
| 25 Jul, 2025 | 5 | FINAL | 25 Jul, 2025 | Equity Share |
| 02 Aug, 2024 | 5 | FINAL | 02 Aug, 2024 | Equity Share |
| 10 Aug, 2023 | 5 | FINAL | 10 Aug, 2023 | Equity Share |
| 11 Aug, 2022 | 5 | FINAL | 12 Aug, 2022 | Equity Share |
| 05 Aug, 2021 | 5 | FINAL | 06 Aug, 2021 | Equity Share |
| 09 Mar, 2020 | 5 | INTERIM | 11 Mar, 2020 | Equity Share |
| 12 Sep, 2019 | 4.5 | FINAL | Equity Share | |
| 12 Sep, 2018 | 3 | FINAL | Equity Share | |
| 16 Aug, 2017 | 3 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,027.20 | ₹807 | ₹1,418.10 | ₹1,625 | ₹4,508 | ₹660 |
| % Change | 2.41% | 0.84% | 0.59% | 0.81% | -0.69% | 1.95% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | ₹642.26 | ₹649.50 | ₹1,421.59 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | ₹172.89 | ₹115.38 | ₹-73.80 | ₹257.90 | ₹255.19 |
| PE TTM | 65.70 | 53.00 | 54.20 | -252.70 | 41.10 | 40.10 |
| 1 Year Return | 87.27 | 36.75 | 136.79 | -18.59 | -14.34 | 14.03 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 992.00
+0.93%
Blue Jet Healthcare Ltd
₹ 575.75
+2.32%
Concord Biotech Ltd.
₹ 1311.20
+4.08%
Aarti Pharmalabs Ltd.
₹ 704.00
+2.59%
Supriya Lifescience Ltd.
₹ 876.50
+1.72%
Alivus Life Sciences Ltd.
₹ 1145.90
+1.40%
Cohance Lifesciences Ltd.
₹ 441.00
+2.37%
Eris Lifesciences Ltd.
₹ 1430.00
+0.99%
Syngene International Ltd.
₹ 415.85
+1.03%
Alembic Pharmaceuticals Ltd.
₹ 816.00
+0.58%
Sun Pharma Advanced Research Company Ltd.
₹ 278.05
+2.99%
Strides Pharma Science Ltd.
₹ 1072.00
-0.81%
FDC Ltd.
₹ 431.70
+1.96%
Shilpa Medicare Ltd.
₹ 624.80
+4.95%
Natco Pharma Ltd.
₹ 961.55
-0.49%
Caplin Point Laboratories Ltd.
₹ 2626.00
+3.86%
Marksans Pharma Ltd.
₹ 278.80
+5.83%
Orchid Pharma Ltd.
₹ 1050.00
+4.76%
Bliss GVS Pharma Ltd.
₹ 526.90
+2.72%
Sanofi India Ltd.
₹ 3349.00
-0.96%
Procter & Gamble Health Ltd.
₹ 6600.00
+5.39%
Jeena Sikho Lifecare Ltd.
₹ 590.00
+4.71%
By signing up I certify terms, conditions & privacy policy